Short answer
CVS Health (CVS) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). John E. Gallina, former CFO of Elevance Health (2016-2023), appointed to CVS Health Board effective March 19, 2026.
CVS Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- John E. Gallina, former CFO of Elevance Health (2016-2023), appointed to CVS Health Board effective March 19, 2026
- Gallina named to Audit Committee, designated audit committee financial expert under SEC rules
- Brings nearly 30 years of finance, audit, and risk management experience in health sector
- Board determined Gallina to be independent under NYSE corporate governance rules
- Director compensation aligned with CVS non-employee director pay, prorated for service start date
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CVS Health 8-K filings
Get the next CVS 8-K as it lands
Follow CVS for push alerts, or ask the research agent what this filing means.